rh5.2
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 3, 2023 (NCT05790889)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05978037 | Phase 1/Phase 2 (Phase 2) | Aug 18, 2023 | University of Oxford |
| NCT05790889 | Phase 1/Phase 2 (Phase 2) | Apr 3, 2023 | European and Developing Countries Clinical Trials Partnership (EDCTP), Institut et Haute école de la Santé, La Source, University of Oxford, Wellcome Trust |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Oxford | Academic/Hospital | 2 | 2 | 1 | 2023 |
| European and Developing Countries Clinical Trials Partnership (EDCTP) | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Institut et Haute école de la Santé, La Source | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1